Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19.

Ariel HammermanRuslan SergienkoMichael FrigerTanya BeckensteinAlon PeretzDoron NetzerShlomit YaronRonen Arbel

Published in: The New England journal of medicine (2022)

Among patients who had recovered from Covid-19, the receipt of at least one dose of the BNT162b2 vaccine was associated with a significantly lower risk of recurrent infection.

Keyphrases

coronavirus disease
sars cov
randomized controlled trial
systematic review
respiratory syndrome coronavirus